Study to evaluate immunogenicity and safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine at 9 and 10 years after vaccine administration and assessment of re-vaccination with 2 additional doses at 10 years after initial vaccination, in healthy subjects aged 60 years of age(YOA) and older

Trial Identifier: 204926
Sponsor: GlaxoSmithKline
Start Date: April 2016
Primary Completion Date: August 2017
Study Completion Date: October 2018
Condition: Other - Conditions

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Czech Republic Hradec Kralove, Czech Republic, 500 01
Germany, Baden-Wuerttemberg Mannheim, Baden-Wuerttemberg, Germany, 68161
Germany, Bayern Wuerzburg, Bayern, Germany, 97070
Germany, Berlin Berlin, Germany, 13347
Germany, Nordrhein-Westfalen Essen, Nordrhein-Westfalen, Germany, 45359
Sweden ESKILSTUNA, Sweden, SE-631 88
Sweden UPPSALA, Sweden, SE-751 85